Drug intelligence / Profile preview

Technosphere insulin

Development stage
Approved
Lead developer
Mannkind
Administration
Inhalation
01

Overview

Technosphere insulin is a dry powder formulation of regular human insulin adsorbed onto Technosphere microparticles for oral inhalation. The primary component of Technosphere particles is fumaryl diketopiperazine (FDKP), which self-assembles into microparticles (2-5μm) under acidic conditions. Upon inhalation, these particles reach the deep lung where they dissolve rapidly at physiological pH, allowing quick absorption of insulin into systemic circulation. Technosphere insulin has a rapid onset of action (approximately 12-15 minutes), peaks at around 45 minutes, and has a duration of about 2-3 hours, making it much faster than traditional subcutaneous insulins. It is designed for mealtime insulin administration in patients with type 1 and type 2 diabetes.

Brand names
Afrezza
Other names
inhaled insulin
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on Technosphere insulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Technosphere insulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call